Cargando…

124 Heterogeneity of Allergen Epitope-specific CD4+ T Cells Responses: Steps Toward Optimal Composition for Peptide-based Immunotherapy

BACKGROUND: Peptide-based allergen immunotherapy is a promising alternative to conventional allergy vaccine. However, the optimal composition of such vaccines, in terms of the choice of the appropriate peptides, has remained unclear. Knowledge of the epitope-specific T cell responses to allergens ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wambre, Erik, Delong, Jonathan, James, Eddie, Torres-Chinn, Nadia, Robinson, David, Kwok, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513055/
http://dx.doi.org/10.1097/01.WOX.0000411869.96996.a9
_version_ 1782251865072730112
author Wambre, Erik
Delong, Jonathan
James, Eddie
Torres-Chinn, Nadia
Robinson, David
Kwok, William
author_facet Wambre, Erik
Delong, Jonathan
James, Eddie
Torres-Chinn, Nadia
Robinson, David
Kwok, William
author_sort Wambre, Erik
collection PubMed
description BACKGROUND: Peptide-based allergen immunotherapy is a promising alternative to conventional allergy vaccine. However, the optimal composition of such vaccines, in terms of the choice of the appropriate peptides, has remained unclear. Knowledge of the epitope-specific T cell responses to allergens can give important information on the pathogenesis and regulation of allergic inflammation. In this study we sought to identify candidate allergen-epitopes that can be used to improve peptide-based allergen immunotherapy. METHODS: Tetramer Guided Epitope Mapping was first used to identify CD4+ T cell epitopes for group 1 and group 5 timothy grass pollen allergens. MHC class II tetramer technology was then used in an ex vivo approach to assess the grass pollen-specific CD4(+) T cell responses in allergic and non-allergic individuals. The frequency, surface marker phenotype and cytokine profile of these cells were directly analysed by flow cytometry. RESULTS: CD4+ T cell responses to Timothy grass allergens are directed to a broad range of epitopes characterized by defined immunodominance hierarchy patterns. We observed heterogeneity of phenotype within the allergen-specific CD4+ T cells that depends on the epitope for which the cells are specific. T cell epitopes associated with production of IL-10 or IFN-g are recognized at low frequencies in both allergic and healthy individuals. In contrast, allergy-associated epitopes are only recognized in allergic individuals by high frequency, terminally differentiated allergen-specific CD4+ T cells, which are susceptible to deletion by repeated stimulation with high doses of antigen. Allergen-specific immunotherapy caused significant changes in the epitopes hierarchy of the grass pollen allergen-specific memory CD4 T cell pool. CONCLUSIONS: The ability to evaluate epitope-specific T cell responses to allergens can give important information on the pathogenesis and regulation of allergic inflammation and could be of great use in designing peptide-based allergy vaccination strategies. Some epitopes may play a prominent role in driving a protective response, while others may directly impair the pathogenic response.
format Online
Article
Text
id pubmed-3513055
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35130552012-12-21 124 Heterogeneity of Allergen Epitope-specific CD4+ T Cells Responses: Steps Toward Optimal Composition for Peptide-based Immunotherapy Wambre, Erik Delong, Jonathan James, Eddie Torres-Chinn, Nadia Robinson, David Kwok, William World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Peptide-based allergen immunotherapy is a promising alternative to conventional allergy vaccine. However, the optimal composition of such vaccines, in terms of the choice of the appropriate peptides, has remained unclear. Knowledge of the epitope-specific T cell responses to allergens can give important information on the pathogenesis and regulation of allergic inflammation. In this study we sought to identify candidate allergen-epitopes that can be used to improve peptide-based allergen immunotherapy. METHODS: Tetramer Guided Epitope Mapping was first used to identify CD4+ T cell epitopes for group 1 and group 5 timothy grass pollen allergens. MHC class II tetramer technology was then used in an ex vivo approach to assess the grass pollen-specific CD4(+) T cell responses in allergic and non-allergic individuals. The frequency, surface marker phenotype and cytokine profile of these cells were directly analysed by flow cytometry. RESULTS: CD4+ T cell responses to Timothy grass allergens are directed to a broad range of epitopes characterized by defined immunodominance hierarchy patterns. We observed heterogeneity of phenotype within the allergen-specific CD4+ T cells that depends on the epitope for which the cells are specific. T cell epitopes associated with production of IL-10 or IFN-g are recognized at low frequencies in both allergic and healthy individuals. In contrast, allergy-associated epitopes are only recognized in allergic individuals by high frequency, terminally differentiated allergen-specific CD4+ T cells, which are susceptible to deletion by repeated stimulation with high doses of antigen. Allergen-specific immunotherapy caused significant changes in the epitopes hierarchy of the grass pollen allergen-specific memory CD4 T cell pool. CONCLUSIONS: The ability to evaluate epitope-specific T cell responses to allergens can give important information on the pathogenesis and regulation of allergic inflammation and could be of great use in designing peptide-based allergy vaccination strategies. Some epitopes may play a prominent role in driving a protective response, while others may directly impair the pathogenic response. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3513055/ http://dx.doi.org/10.1097/01.WOX.0000411869.96996.a9 Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Wambre, Erik
Delong, Jonathan
James, Eddie
Torres-Chinn, Nadia
Robinson, David
Kwok, William
124 Heterogeneity of Allergen Epitope-specific CD4+ T Cells Responses: Steps Toward Optimal Composition for Peptide-based Immunotherapy
title 124 Heterogeneity of Allergen Epitope-specific CD4+ T Cells Responses: Steps Toward Optimal Composition for Peptide-based Immunotherapy
title_full 124 Heterogeneity of Allergen Epitope-specific CD4+ T Cells Responses: Steps Toward Optimal Composition for Peptide-based Immunotherapy
title_fullStr 124 Heterogeneity of Allergen Epitope-specific CD4+ T Cells Responses: Steps Toward Optimal Composition for Peptide-based Immunotherapy
title_full_unstemmed 124 Heterogeneity of Allergen Epitope-specific CD4+ T Cells Responses: Steps Toward Optimal Composition for Peptide-based Immunotherapy
title_short 124 Heterogeneity of Allergen Epitope-specific CD4+ T Cells Responses: Steps Toward Optimal Composition for Peptide-based Immunotherapy
title_sort 124 heterogeneity of allergen epitope-specific cd4+ t cells responses: steps toward optimal composition for peptide-based immunotherapy
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513055/
http://dx.doi.org/10.1097/01.WOX.0000411869.96996.a9
work_keys_str_mv AT wambreerik 124heterogeneityofallergenepitopespecificcd4tcellsresponsesstepstowardoptimalcompositionforpeptidebasedimmunotherapy
AT delongjonathan 124heterogeneityofallergenepitopespecificcd4tcellsresponsesstepstowardoptimalcompositionforpeptidebasedimmunotherapy
AT jameseddie 124heterogeneityofallergenepitopespecificcd4tcellsresponsesstepstowardoptimalcompositionforpeptidebasedimmunotherapy
AT torreschinnnadia 124heterogeneityofallergenepitopespecificcd4tcellsresponsesstepstowardoptimalcompositionforpeptidebasedimmunotherapy
AT robinsondavid 124heterogeneityofallergenepitopespecificcd4tcellsresponsesstepstowardoptimalcompositionforpeptidebasedimmunotherapy
AT kwokwilliam 124heterogeneityofallergenepitopespecificcd4tcellsresponsesstepstowardoptimalcompositionforpeptidebasedimmunotherapy